WASHINGTON -(Dow Jones)- A Food and Drug Administration panel will discuss GlaxoSmithKline PLC’s (GSK, GSK.LN) Rotarix infant vaccine on May 7. Last month, the agency recommended doctors stop using after a virus was found in the product.
WASHINGTON -(Dow Jones)- A Food and Drug Administration panel will discuss GlaxoSmithKline PLC’s (GSK, GSK.LN) Rotarix infant vaccine on May 7. Last month, the agency recommended doctors stop using after a virus was found in the product.
